Breaking News

Home / NYT / Moderna and Pfizer-BioNTech reconsider their battle plans after a variant proves more challenging.

Moderna and Pfizer-BioNTech reconsider their battle plans after a variant proves more challenging.

January 25, 2021

By BY DENISE GRADY from NYT World https://ift.tt/39maxRf
via IFTTT

No comments

Subscribe to: Post Comments ( Atom )